Quantitative assessment of cerebral gray matter density change in progressive supranuclear palsy using voxel based morphometry analysis and cerebral MR T1-weighted FLAIR imaging-Reference-Cited by-同舟云学术

Quantitative assessment of cerebral gray matter density change in progressive supranuclear palsy using voxel based morphometry analysis and cerebral MR T1-weighted FLAIR imaging

Published:2015-12 Issue:1-2 Volume:359 Page:367-372
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Wang Guihong,Wang Jingjuan,Zhan Jiong,Nie Binbin,Li Panlong,Fan Lidan,Zhu Haitao,Feng Tao,Shan Baoci

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference45 articles.

1. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia;Steele;Arch. Neurol.,1964

2. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP International Workshop;Litvan;Neurology,1996

3. The clinical and pathological spectrum of Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy): a reappraisal;Daniel;Brain,1995

4. Fifty years of progressive supranuclear palsy;Colosimo;J. Neurol. Neurosurg. Psychiatry,2014

5. Magnetic resonance imaging in progressive supranuclear palsy;Stamelou;J. Neurol.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimaging in progressive supranuclear palsy;Neuroimaging in Parkinson�s Disease and Related Disorders;2023

2. Cerebrospinal fluid T1 value phantom reproduction at scan room temperature;Journal of Applied Clinical Medical Physics;2019-06-09

3. Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy;NeuroImage: Clinical;2019

4. Brain gray matter abnormalities in progressive supranuclear palsy revisited;Oncotarget;2017-09-15

5. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?;Movement Disorders;2017-05-13